tradingkey.logo
tradingkey.logo
Buscar

Inspire Medical Systems Inc

INSP
Añadir a la lista de seguimiento
42.660USD
+0.740+1.77%
Cierre 05/14, 16:00ETCotizaciones retrasadas 15 min
1.23BCap. mercado
9.57P/E TTM

Inspire Medical Systems Inc

42.660
+0.740+1.77%

Más Datos de Inspire Medical Systems Inc Compañía

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Información de Inspire Medical Systems Inc

Símbolo de cotizaciónINSP
Nombre de la empresaInspire Medical Systems Inc
Fecha de salida a bolsaMay 03, 2018
Director ejecutivoHerbert (Timothy P)
Número de empleados1246
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 03
Dirección5500 Wayzata Blvd Ste 1600
CiudadGOLDEN VALLEY
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal55416-1237
Teléfono17639575037
Sitio Webhttps://www.inspiresleep.com/
Símbolo de cotizaciónINSP
Fecha de salida a bolsaMay 03, 2018
Director ejecutivoHerbert (Timothy P)

Ejecutivos de Inspire Medical Systems Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.83K
-61.31%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
27.29K
+14.18%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
19.95K
+77.24%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
9.87K
-218.82%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
8.47K
+46.09%
Mr. Randall A. (Randy) Ban
Mr. Randall A. (Randy) Ban
Executive Vice President - Patient Access and Therapy Development
Executive Vice President - Patient Access and Therapy Development
--
--
Mr. Richard J. (Rick) Buchholz
Mr. Richard J. (Rick) Buchholz
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dana G. Mead, Jr.
Mr. Dana G. Mead, Jr.
Independent Director
Independent Director
--
--
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
--
--
Mr. Gary L. Ellis
Mr. Gary L. Ellis
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.83K
-61.31%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
27.29K
+14.18%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
19.95K
+77.24%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
9.87K
-218.82%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
8.47K
+46.09%
Mr. Randall A. (Randy) Ban
Mr. Randall A. (Randy) Ban
Executive Vice President - Patient Access and Therapy Development
Executive Vice President - Patient Access and Therapy Development
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
872.09M
95.63%
All other countries
39.90M
4.37%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.06%
Wellington Management Company, LLP
7.67%
Vanguard Portfolio Management, LLC
5.68%
Deerfield Management Company, L.P.
5.23%
Vanguard Capital Management, LLC
4.40%
Otro
65.96%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.06%
Wellington Management Company, LLP
7.67%
Vanguard Portfolio Management, LLC
5.68%
Deerfield Management Company, L.P.
5.23%
Vanguard Capital Management, LLC
4.40%
Otro
65.96%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
47.79%
Investment Advisor/Hedge Fund
38.46%
Hedge Fund
22.74%
Research Firm
8.72%
Pension Fund
1.92%
Individual Investor
1.25%
Bank and Trust
0.80%
Venture Capital
0.65%
Sovereign Wealth Fund
0.45%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
841
34.93M
121.22%
-6.43M
2025Q4
829
33.78M
116.26%
-6.67M
2025Q3
828
32.29M
111.12%
-7.29M
2025Q2
883
35.48M
119.97%
-4.91M
2025Q1
912
35.71M
121.08%
-5.66M
2024Q4
874
35.22M
118.69%
-4.72M
2024Q3
852
35.48M
118.45%
-2.86M
2024Q2
825
33.60M
112.73%
-2.85M
2024Q1
801
33.20M
111.87%
-2.01M
2023Q4
786
32.35M
109.45%
+751.92K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
3.19M
11.06%
-1.55K
-0.05%
Dec 31, 2025
Wellington Management Company, LLP
2.21M
7.68%
+2.21M
--
Dec 31, 2025
Deerfield Management Company, L.P.
1.51M
5.23%
+29.57K
+2.00%
Dec 31, 2025
D. E. Shaw & Co., L.P.
1.21M
4.21%
+853.30K
+237.78%
Dec 31, 2025
William Blair Investment Management, LLC
1.16M
4.03%
-136.29K
-10.50%
Dec 31, 2025
Morgan Stanley & Co. LLC
940.51K
3.27%
+578.85K
+160.05%
Dec 31, 2025
State Street Investment Management (US)
918.50K
3.19%
-60.80K
-6.21%
Dec 31, 2025
Artisan Partners Limited Partnership
785.74K
2.73%
+259.50K
+49.31%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Global X HealthTech ETF
2.68%
State Street SPDR S&P Health Care Equipment ETF
1.63%
Invesco S&P SmallCap Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.53%
iShares S&P Small-Cap 600 Growth ETF
0.43%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
0.27%
WisdomTree US SmallCap Quality Growth Fund
0.26%
Ver más
Global X HealthTech ETF
Proporción2.68%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.63%
Invesco S&P SmallCap Health Care ETF
Proporción1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción0.53%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.43%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proporción0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporción0.27%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.26%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI